Therapeutic miR-132 inhibition reverses heart failure

31 August 2019 (14:32 - 14:46)

Organised by:

About the speaker

Professor Thomas Thum

Institute for Molecular and Translational Therapeutic Strategies (IMTTS), Hannover (Germany)

4 More presentations in this session

Presentation thumbnail

Exome variants influencing cholesterol levels and the risk of recurrent ischemic events after early-onset myocardial infarction

Doctor D. Ardissino (Ospedale parma, IT)

Presentation thumbnail

In silico model for specific antigen-driven response of T-lymphocytes in the epicardial adipose tissue: unravelling the intricate skein of microbiota involvement in acute coronary syndromes

Doctor D. Pedicino (Rome, IT)

Presentation thumbnail

A different microbial signature in plaque and gut of patients presenting with ACS: a possible role for coronary instability

Doctor P. Eugenia (Rome, IT)

Presentation thumbnail

Circulating dipeptidyl peptidase-3 is a myocardial depressant factor: Procizumab promptly and sustainably restored hemodynamics in heart failure

Professor A. Mebazaa (Paris, FR)

Access the full session

Session thumbnail

Late Breaking Basic and Translational Science - Acute Coronary Syndromes and Heart Failure

The Event

ESC Congress 2019

31 August 2019 14:32 CET

You may be interested in

Congress Session

Heart failure in the era of precision medicine: insights into pathophysiology and emerging treatments

Congress Session

Which device might help your HFpEF patient?

Congress Session

From genetic signatures to clinical implications

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources